{"id":23879,"date":"2013-11-01T12:51:17","date_gmt":"2013-11-01T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23879"},"modified":"2018-04-14T02:09:23","modified_gmt":"2018-04-14T07:09:23","slug":"23879","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23879\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 1\u00ba de novembro de 2013"},"content":{"rendered":"

vers\u00e3o impressa<\/a><\/p>\n

***********************************
\nBrakke Consulting's
\nNot\u00edcias e notas sobre sa\u00fade animal de 1\u00ba de novembro de 2013<\/strong>
\nCopyright \u00a9 Brakke Consulting, Inc.
\n 
\nEditor: Lynn Fondon DVM MBA
\n************************************
\nNAS NOTICIAS:
\n 
\nNovidades da Brakke Consulting<\/u>
\nplanejamento estrat\u00e9gico
\n 
\nnot\u00edcias de ganhos<\/u>
\nBayer
\nHester Bioci\u00eancias
\nMerck
\nMerial
\n 
\noutras not\u00edcias<\/u>
\nAbaxis
\nAlfaVax
\nAlst\u00f3e
\nAurora Farmac\u00eautica
\nHarrisvaccines
\nLamdaGen
\nNeogen
\nNext
\nPetco
\nPrima Tech
\nSogeval
\n 
\n************************************
\nBRAKKE CONSULTING, INC.
\nSERVI\u00c7OS DE PLANEJAMENTO ESTRAT\u00c9GICO
\n<\/strong> 
\nA Brakke Consulting \u00e9 um excelente recurso para o planejamento estrat\u00e9gico da sua empresa. Alguns dos servi\u00e7os que oferecemos incluem:
\n\u2013 Revis\u00e3o das estimativas de receita e probabilidade de sucesso do seu pipeline de produtos.
\n\u2013 Revisar o cronograma de v\u00e1rias introdu\u00e7\u00f5es de novos produtos e estimar o impacto de v\u00e1rios cen\u00e1rios.
\n\u2013 Benchmarking de v\u00e1rias fun\u00e7\u00f5es em rela\u00e7\u00e3o aos concorrentes da empresa nos mercados maiores, o que pode incluir o tamanho da for\u00e7a de vendas, servi\u00e7os t\u00e9cnicos e\/ou gastos com P&D versus vendas.<\/p>\n

Por meio do planejamento estrat\u00e9gico, a Brakke Consulting pode ajudar a aumentar a probabilidade de sucesso dos empreendimentos futuros de sua empresa.<\/p>\n

Contacte-nos para assist\u00eancia profissional em qualquer uma destas \u00e1reas.
\n 
\nwww.BrakkeConsulting.com<\/a>
\n 
\n***********************************
\nRELEASES DE RESULTADOS DA EMPRESA
\n 
\n> A Merck anunciou os resultados financeiros do terceiro trimestre de 2013. As vendas de Sa\u00fade Animal totalizaram $800 milh\u00f5es no terceiro trimestre de 2013, um decl\u00ednio de 2% em compara\u00e7\u00e3o com o terceiro trimestre de 2012, incluindo um impacto negativo de 2% devido ao c\u00e2mbio estrangeiro. O trimestre foi afetado negativamente pela suspens\u00e3o volunt\u00e1ria das vendas de Zilmax anunciada anteriormente. (comunicado de imprensa da empresa)
\n 
\n> A Sanofi reportou resultados financeiros para o terceiro trimestre de 2013. As vendas da Merial foram de 458 milh\u00f5es de euros ($619 milh\u00f5es), uma queda de 6% devido ao aumento da concorr\u00eancia com a Frontline. (site da companhia)
\n 
\n> A Bayer reportou resultados financeiros para o terceiro trimestre de 2013. As vendas da Divis\u00e3o de Sa\u00fade Animal foram de 321 milh\u00f5es de euros ($434 milh\u00f5es), uma queda de 6% em compara\u00e7\u00e3o com o terceiro trimestre de 2012 (um aumento de 1,5% ajustado \u00e0 moeda e ao portf\u00f3lio). (site da companhia) 
\n 
\n> Resultados da Hester Biosciences para o primeiro semestre do exerc\u00edcio financeiro encerrado em 30 de setembro de 2013.
\nO volume de neg\u00f3cios do primeiro semestre foi de 313 milh\u00f5es de rupias ($5,1 milh\u00f5es), um aumento de 7% em compara\u00e7\u00e3o com o mesmo per\u00edodo de 2012. O lucro l\u00edquido ap\u00f3s impostos caiu 18% para 36,29 milh\u00f5es de rupias ($591.000) no semestre. (Farm\u00e1cia Animal)  
\n 
\n************************************
\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA
\n 
\n> A Neogen Corporation anunciou que adquiriu os ativos da Prima Tech Incorporated, uma empresa de instrumentos veterin\u00e1rios com sede na Carolina do Norte. Os termos financeiros n\u00e3o foram divulgados. (comunicado de imprensa da empresa) 
\n 
\n> A Aurora Pharmaceutical anunciou que o Balance Stress & Dehydration Aid, um suplemento nutricional\/metab\u00f3lico para gado, j\u00e1 est\u00e1 dispon\u00edvel. Balance \u00e9 formulado com eletr\u00f3litos e agentes tamponantes e n\u00e3o utiliza a\u00e7\u00facar como enchimento. (comunicado de imprensa da empresa) 
\n 
\n> A Abaxis, Inc. e a LamdaGen Corporation anunciaram um acordo de P&D para integrar a tecnologia Plasmonic ELISA de alta sensibilidade da LamdaGen nos rotores Abaxis Piccolo e VetScan. (Wall Street Journal) 
\n 
\n> A Harrisvaccines anunciou que expandiu seu contrato de licen\u00e7a exclusivo com a AlphaVax, Inc. para incluir todas as doen\u00e7as de animais de companhia, al\u00e9m de todas as doen\u00e7as de animais de produ\u00e7\u00e3o. A tecnologia da plataforma de part\u00edculas de RNA (RP) da Harrisvaccines utiliza uma sequ\u00eancia gen\u00e9tica de v\u00edrus espec\u00edficos, que pode ser submetida eletronicamente, para criar uma vacina espec\u00edfica para cepa em quest\u00e3o de semanas. A Harrisvaccines iniciar\u00e1 seu trabalho no mundo dos animais de companhia desenvolvendo vacinas para uma variedade de doen\u00e7as respirat\u00f3rias em c\u00e3es. (PRNewswire) 
\n 
\n> AUSTR\u00c1LIA A Nexvet Biopharma anunciou que levantou AUD$7 milh\u00f5es por meio de um aumento de capital com excesso de subscri\u00e7\u00f5es. O sindicato de compras inclu\u00eda uma s\u00e9rie de novos investidores norte-americanos, indiv\u00edduos com elevado patrim\u00f3nio l\u00edquido e a empresa australiana de investimento em ci\u00eancias da vida, BioScience Managers, que constituiu o pilar da ronda de angaria\u00e7\u00e3o de capital com um investimento de $3 milh\u00f5es. (DigitalJournal. com) 
\n 
\n> Reino Unido Ap\u00f3s a aquisi\u00e7\u00e3o da Alstoe Ltd pela Sogeval SA em janeiro de 2013, a empresa decidiu alterar a sua designa\u00e7\u00e3o comercial e, a partir de 1 de novembro de 2013, o neg\u00f3cio passar\u00e1 a chamar-se Sogeval UK Ltd.
\n 
\n> M\u00c9XICO A Petco anunciou que abriu sua primeira loja no M\u00e9xico e anunciou planos de expans\u00e3o cont\u00ednua no M\u00e9xico e na Am\u00e9rica Latina por meio de uma joint venture previamente anunciada com o Grupo Gigante do M\u00e9xico. Juntas, as empresas planejam abrir at\u00e9 50 lojas Petco no M\u00e9xico e na Am\u00e9rica Latina at\u00e9 2020. (Atualiza\u00e7\u00e3o eletr\u00f4nica da APPA \u2013 Retailing Today) 
\n 
\n***********************************
\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL
\n 
\n> JAP\u00c3O \u2013 TESTE DE GRIPE AVI\u00c1RIA Cientistas no Jap\u00e3o desenvolveram uma nova tecnologia de diagn\u00f3stico r\u00e1pido para detectar o v\u00edrus H7N9 da gripe avi\u00e1ria altamente patog\u00eanico. A nova tecnologia determina a rea\u00e7\u00e3o de liga\u00e7\u00e3o entre o v\u00edrus em uma amostra humoral de uma ave e uma glicocadeia humana produzida artificialmente no kit de diagn\u00f3stico. O teste \u00e9 capaz de dar resultado em 30 minutos. Os desenvolvedores prev\u00eaem que o teste poder\u00e1 estar dispon\u00edvel comercialmente dentro de tr\u00eas anos. (Farm\u00e1cia Animal)
\n 
\n***********************************
\nPONTO DE VISTA DA BRAKKE CONSULTORIA<\/p>\n

No boletim informativo desta semana, tr\u00eas das cinco principais empresas de sa\u00fade animal anunciaram receitas do terceiro trimestre inferiores \u00e0s planeadas. Quando estes resultados s\u00e3o combinados com os aumentos de receitas comunicados na semana passada por algumas das outras empresas l\u00edderes, as tend\u00eancias s\u00e3o um pouco menos optimistas do que o relatado anteriormente. Quando as demais empresas reportarem seus resultados teremos uma vis\u00e3o mais clara do que ocorreu no mercado e para onde estamos caminhando nos \u00faltimos meses do ano. As tend\u00eancias de 2013 ser\u00e3o transferidas para 2014? Que novos produtos e tecnologias entrar\u00e3o no mercado em 2014 para impulsionar as tend\u00eancias de crescimento?<\/p>\n

Tenha um \u00f3timo fim de semana!!<\/p>\n

Ron Brakke
\n 
\n**********************************<\/p>\n

Este boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.
\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.
\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em www.brakkeconsulting.com<\/a>.
\n 
\nBrakke Consulting, Inc.
\n12005 Ford Rd., Suite 530
\nDallas, TX 75234 EUA<\/p>\n

 <\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

vers\u00e3o impressa ************************************ Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 1\u00ba de novembro de 2013 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting planejamento estrat\u00e9gico not\u00edcias sobre lucros Bayer Hester Biosciences Merck Merial outras not\u00edcias Abaxis AlphaVax Alstoe Aurora Pharmaceutical Harrisvaccines LamdaGen Neogen Nexvet Petco Prima Tech Sogeval ************************************ BRAKKE CONSULTING, INC. SERVI\u00c7OS DE PLANEJAMENTO ESTRAT\u00c9GICO A Brakke Consulting \u00e9 um excelente recurso para o planejamento estrat\u00e9gico da sua empresa. Alguns dos servi\u00e7os que oferecemos incluem: \u2013 Revis\u00e3o das estimativas de receita e probabilidade de sucesso do seu pipeline de produtos. \u2013 Revis\u00e3o do momento de v\u00e1rios lan\u00e7amentos de novos produtos e estimativa do impacto de v\u00e1rios cen\u00e1rios. \u2013 Benchmarking de v\u00e1rias fun\u00e7\u00f5es em rela\u00e7\u00e3o aos concorrentes da empresa em mercados maiores, o que pode incluir tamanho da for\u00e7a de vendas, servi\u00e7os t\u00e9cnicos e\/ou gastos com P&D versus vendas. Por meio do planejamento estrat\u00e9gico, a Brakke Consulting pode ajudar a melhorar a probabilidade de sucesso dos empreendimentos futuros da sua empresa. Entre em contato conosco para obter assist\u00eancia profissional em qualquer uma dessas \u00e1reas. www.BrakkeConsulting.com ************************************ DIVULGA\u00c7\u00d5ES DE LUCROS DA EMPRESA > A Merck anunciou os resultados financeiros do terceiro trimestre de 2013. As vendas de Sa\u00fade Animal totalizaram $800 milh\u00f5es no terceiro trimestre de 2013, um decl\u00ednio de 2% em compara\u00e7\u00e3o com o terceiro trimestre de 2012, incluindo um impacto negativo de 2% devido ao c\u00e2mbio. O trimestre foi afetado negativamente por<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23879","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23879\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting’s Animal Health News & Notes for November 1, 2013 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news strategic planning   earnings news Bayer Hester Biosciences Merck Merial   other news Abaxis AlphaVax Alstoe Aurora Pharmaceutical Harrisvaccines LamdaGen Neogen Nexvet Petco Prima Tech Sogeval   ************************************ BRAKKE CONSULTING, INC. STRATEGIC PLANNING SERVICES   Brakke Consulting is an excellent resource for your company’s strategic planning. Some of the services we offer include: – Reviewing revenue estimates and success probability of your product pipeline. – Reviewing the timing of various new product introductions and estimate the impact of various scenarios. – Benchmarking various functions against company competitors in the larger markets, which might include sales force size, technical services and\/or R&D spending vs. sales. Through strategic planning, Brakke Consulting can help improve the likelihood of success for your company’s future endeavors. Contact us for professional assistance in any of these areas.   www.BrakkeConsulting.com   *********************************** COMPANY EARNINGS RELEASES   > Merck announced financial results for the third quarter of 2013. Animal Health sales totaled $800 million for the third quarter of 2013, a 2% decline compared with the third quarter of 2012, including a 2% negative impact due to foreign exchange. The quarter was negatively affected byView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23879\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2013-11-01T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:09:23+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23879\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23879\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for November 1, 2013\",\"datePublished\":\"2013-11-01T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:09:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23879\/\"},\"wordCount\":945,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23879\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23879\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2013-11-01T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:09:23+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23879\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23879\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23879\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for November 1, 2013\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23879\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting’s Animal Health News & Notes for November 1, 2013 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news strategic planning   earnings news Bayer Hester Biosciences Merck Merial   other news Abaxis AlphaVax Alstoe Aurora Pharmaceutical Harrisvaccines LamdaGen Neogen Nexvet Petco Prima Tech Sogeval   ************************************ BRAKKE CONSULTING, INC. STRATEGIC PLANNING SERVICES   Brakke Consulting is an excellent resource for your company’s strategic planning. Some of the services we offer include: – Reviewing revenue estimates and success probability of your product pipeline. – Reviewing the timing of various new product introductions and estimate the impact of various scenarios. – Benchmarking various functions against company competitors in the larger markets, which might include sales force size, technical services and\/or R&D spending vs. sales. Through strategic planning, Brakke Consulting can help improve the likelihood of success for your company’s future endeavors. Contact us for professional assistance in any of these areas.   www.BrakkeConsulting.com   *********************************** COMPANY EARNINGS RELEASES   > Merck announced financial results for the third quarter of 2013. Animal Health sales totaled $800 million for the third quarter of 2013, a 2% decline compared with the third quarter of 2012, including a 2% negative impact due to foreign exchange. The quarter was negatively affected byView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23879\/","og_site_name":"Brakke Consulting Website","article_published_time":"2013-11-01T18:51:17+00:00","article_modified_time":"2018-04-14T07:09:23+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23879\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23879\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for November 1, 2013","datePublished":"2013-11-01T18:51:17+00:00","dateModified":"2018-04-14T07:09:23+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23879\/"},"wordCount":945,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23879\/","url":"https:\/\/brakkeconsulting.com\/23879\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2013-11-01T18:51:17+00:00","dateModified":"2018-04-14T07:09:23+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23879\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23879\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23879\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for November 1, 2013"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23879"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23879\/revisions"}],"predecessor-version":[{"id":25416,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23879\/revisions\/25416"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}